{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:33:41Z","timestamp":1761514421482,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01527","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:21:29Z","timestamp":1562718089000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sj\u00f6gren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors"],"prefix":"10.3389","volume":"10","author":[{"given":"Luca","family":"Quartuccio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saviana","family":"Gandolfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alen","family":"Zabotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Zandonella Callegher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Fabro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","article-title":"National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthrit Rheum."},{"key":"B2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/rheumatology\/kei107","article-title":"Epidemiology of primary Sj\u00f6gren's syndrome in north-west Greece, 1982-2003","volume":"45","author":"Alamanos","year":"2006","journal-title":"Rheumatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e3821","DOI":"10.1136\/bmj.e3821","article-title":"Primary sjogren syndrome","volume":"344","author":"Ramos-Casals","year":"2012","journal-title":"BMJ."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2012.01.006","article-title":"Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects","volume":"39","author":"Tzioufas","year":"2012","journal-title":"J Autoimmun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","article-title":"Prognosis and outcome of non-Hodgkin lymphoma in primary Sj\u00f6gren syndrome","volume":"91","author":"Voulgarelis","year":"2012","journal-title":"Medicine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","article-title":"Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients","volume":"53","author":"Baldini","year":"2014","journal-title":"Rheumatology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sj\u00f6gren's task force. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jaut.2013.12.010","article-title":"Outcome measures for primary Sj\u00f6gren's syndrome: a comprehensive review","volume":"51","author":"Seror","year":"2014","journal-title":"J Autoimmun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","article-title":"EULAR Sj\u00f6gren's task force. Validation of EULAR primary Sj\u00f6gren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)","volume":"74","author":"Seror","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B10","first-page":"150","article-title":"The evaluation of disease activity in Sj\u00f6gren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study","volume":"36","author":"De Vita","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1093\/rheumatology\/kev257","article-title":"Efficacy and safety of belimumab given for 12 months in primary Sj\u00f6gren's syndrome: the BELISS open-label phase II study","volume":"54","author":"De Vita","year":"2015","journal-title":"Rheumatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/ard.53.10.637","article-title":"The European Community Study Group on diagnostic criteria for Sj\u00f6gren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sj\u00f6gren's syndrome","volume":"53","author":"Vitali","year":"1994","journal-title":"Ann Rheum Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","article-title":"Eular Sj\u00f6gren syndrome task force. Early diagnosis of primary Sj\u00f6gren's syndrome: EULAR-SS task force clinical recommendations","volume":"12","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Exp Rev Clin Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","article-title":"EULAR Sj\u00f6gren's Task Force. Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren's syndrome with EULAR primary Sj\u00f6gren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)","volume":"75","author":"Seror","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/annrheumdis-2011-200766","article-title":"Clinical applicability of the EULAR Sjogren's syndrome disease activity index: a cumulative ESSDAI score adds in describing disease severity","volume":"71","author":"Risselada","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","article-title":"SS Study Group; Autoimmune Diseases Study Group (GEAS) of the Spanish Society of Internal Medicine (SEMI). Systemic involvement in primary Sjogren's syndrome valuated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)","volume":"53","author":"Ramos-Casals","year":"2014","journal-title":"Rheumatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren's syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.intimp.2015.03.027","article-title":"SS study group, Autoimmune Diseases Study Group (GEAS), Spanish Society of Internal Medicine (SEMI). How are we treating our systemic patients with primary Sj\u00f6gren syndrome? Analysis of 1120 patients","volume":"27","author":"Gheitasi","year":"2015","journal-title":"Int Immunopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sj\u00f6gren's syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3424136","DOI":"10.1155\/2018\/3424136","article-title":"Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus","volume":"2018","author":"Floris","year":"2018","journal-title":"Mediat Inflamm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/annrheumdis-2017-211836","article-title":"Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"77","author":"Rempenault","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","article-title":"Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: the JOQUER randomized clinical trial","volume":"312","author":"Gottenberg","year":"2014","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/rheumatology\/kew194","article-title":"Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sj\u00f6gren syndrome: analysis of 515 patients","volume":"55","author":"Retamozo","year":"2016","journal-title":"Rheumatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/acr.22968","article-title":"Treatment guidelines for rheumatologic manifestations of Sj\u00f6gren's syndrome: use of biologic agents, management of fatigue, and inflammatory musculoskeletal pain","volume":"69","author":"Carsons","year":"2017","journal-title":"Arthritis Care Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e000179","DOI":"10.1136\/rmdopen-2015-000179","article-title":"Epidemiology of neurological manifestations in Sj\u00f6gren's syndrome: data from the French ASSESS Cohort","volume":"2","author":"Carvajal Alegria","year":"2016","journal-title":"RMD Open."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3899\/jrheum.161465","article-title":"Cryoglobulinemia in Sj\u00f6gren syndrome: a disease subset that links higher systemic disease activity, autoimmunity, and local B cell proliferation in mucosa-associated lymphoid tissue","author":"Quartuccio","year":"2017","journal-title":"J Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/rheumatology\/kex490","article-title":"UK primary sj\u00f6gren's syndrome registry, Versnel MA. Systemic interferon type I and type II signatures in primary Sj\u00f6gren's syndrome reveal differences in biological disease activity","volume":"57","author":"Bodewes","year":"2018","journal-title":"Rheumatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13293-017-0137-7","article-title":"Difference in clinical presentation between women and men in incident primary Sj\u00f6gren's syndrome","volume":"8","author":"Ram\u00edrez","year":"2017","journal-title":"Biol Sex Differ."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01527\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:21:30Z","timestamp":1562718090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01527\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,10]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2019.01527"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01527","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2019,7,10]]},"article-number":"1527"}}